UPDATE: RBC Capital Upgrades Boston Scientific (BSX) to Top Pick
Tweet
Share
E-mail
Get Alerts BDX Hot Sheet
Price: $190.21 +0.23%
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Join SI Premium – FREE
(Updated - January 5, 2018 6:12 AM EST)
RBC Capital upgraded Boston Scientific (NYSE: BSX) from Outperform to Top Pick with a price target of $31.00.
Analyst Glenn Novarro comments "BSX shares offer the best risk/reward balance within our large-cap coverage. Fourth quarter earnings, due out February 1, will be a positive catalyst by eliminating concerns around 2018 guidance that have afflicted BSX shares since the company announced another delay in LOTUS Edge on 11/28/17."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- Freedom Broker Downgrades CF Industries (CF) to Hold, 'Strong Half, Softer Base Ahead'
- Morgan Stanley Downgrades Qifu Technology (QFIN) to Equalweight
Create E-mail Alert Related Categories
Analyst Comments, Hot Upgrades, UpgradesRelated Entities
RBC Capital, Earnings, RBC Capital Top PickSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
